Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment

NCT02211560 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

97

Enrollment

INDUSTRY

Sponsor class

Stopped Due to difficulties in patient recruitment

Conditions

Mild Cognitive Impairment

Interventions

OTHER: Phosphatidylserine
OTHER: Placebo

Sponsor

Enzymotec